LCASVD Meeting: March 12th and 13th, 2013
Munich, Germany
Meeting Schedule
Transatlantic Network of Excellence on the Pathogenesis of Small Vessel Disease of the Brain
Research Meeting 1
Munich, March 12-13, 2013
Munich, Germany
Tuesday
12:00-13:00
Lunch
13:00-13:15
Martin Dichgans: Welcome and Opening
Institute for Stroke and Dementia Research
14:00-14:30
Overview of the Network
Anne Joutel and Mark Nelson
Session 1: Faraci Lab Introduction (postponed from kick off meeting, Paris, 2012)
13:30-14:25
Frank Faraci
University of Iowa
Session 2: Common denominators between CADASIL, CARASIL and non-Mendelian SVD: Population-based studies
14:30-15:00
S茅phanie Debette/Ganesh Chauhan
University of Bordeaux
Coffee Break
Session 3: Common denominators between CADASIL, CARASIL and non-Mendelian SVD: Molecular mechanisms/targets
15:15-15:35
Michael De Silva
University of Iowa
15:35-15:55
Katie Dunn
University of Vermont
15:55-16:15
Tom Longden
University of Vermont
Break/Virtual Connection with Ayata Lab, Boston
16:20-16:40
Katharina Eikermann-Haerter
Harvard University
16:40-17:00
Jessica Seidel
Harvard University
10:00-10:30
Frank M Faraci
University of Iowa
Roundtable Discussion: Logistics and Network Optimization
Wednesday
Session 4: Genes/gene products driving small vessel pathology in CADASIL and CARASIL
09:00-09:20
Eva Scharrer
Institute for Stroke and Dementia Research
09:20-09:40
Nathalie Beaufort
Institute for Stroke and Dementia Research
09:40-10:00
Emmanuel Cognat
University of Paris
Coffee Break
Session 5: Mechanisms linking Notch3 and HtrA1 mutations to brain pathology in CADASIL and CARASIL
10:20-10:40
Christel Kr酶igaard
University of Vermont
10:40-11:00
Fabrice Dabertrand
University of Vermont
11:00-11:20
Emmanuel Cognat
University of Paris
11:25-12:20
Round Table and Open Discussion
Lunch
Session 6: Leducq Center Against Small Vessel Disease
14:30-15:15
Allison Sturtevant: Administrative Updates
University of Vermont
15:15-15:45
Network Updates (Anne Joutel and Mark Nelson)
15:45-16:00
Martin Dichgans: Final Remarks and Conclusions
Institute for Stroke and Dementia Research